?Dimethocaine Hydrochloride (CAS 553-63-9)?
? ?Product Profile?
Dimethocaine Hydrochloride, a synthetic local anesthetic agent with the molecular formula ?C??H??N?O?·ClH?, is distinguished by its nerve-blocking efficacy and structural uniqueness compared to traditional anesthetics?13. It is primarily employed in pharmaceutical research and preclinical applications due to its reversible inhibition of sodium channels, enabling precise neurological studies?24.

? ?Core Features?
?? ?Pharmaceutical-Grade Purity?: ≥99% (HPLC-validated), ensuring reliability in sensitive formulations?15.
?? ?Thermal Stability?: Melting point ?196–197°C?, suitable for controlled storage and global distribution?36.
?? ?Regulatory Alignment?: Complies with ?USP42? standards, meeting stringent pharmacopeial requirements?57.

? ?Primary Applications?

• ?Medical Research?: Preclinical evaluation of local anesthesia mechanisms?.

• ?Neurological Studies?: Signal transmission inhibition in experimental models?.

• ?Drug Development?: Intermediate for novel anesthetic agents with reduced systemic toxicity?.

? ?Quality Assurance?
Rigorous testing via ?HPLC?, ?FTIR?, and ?mass spectrometry?, supported by batch-specific Certificates of Analysis (COAs)?
. Stability studies confirm compliance with ICH guidelines for long-term storage?.

? ?Market Relevance?
The global anesthetic market is projected to grow at ?5.2% CAGR (2025–2030)?, driven by advancements in surgical techniques and demand for safer alternatives?
. Dimethocaine Hydrochloride remains integral to R&D efforts targeting enhanced therapeutic profiles?
.